Abstract |
Megakaryopoiesis is associated with inflammatory reactions. To investigate the role of interferon regulatory factors (IRFs) in inflammation-associated megakaryopoiesis, mouse bone marrow hematopoietic stem cells (HSCs) were analyzed. IFN-gamma treatment induced IRF-2 expression as well as the expression of CD41 and IRF-1 in HSCs. An in vitro clonogenic assay showed that IRF-2- but not IRF-1-overexpressing cells increased the number of megakaryocytic colonies. IRF-2 transfection up-regulated CD41 promoter activity in hematopoietic cell lines. The number of CD41-positive bone marrow cells increased in mice injected with IRF-2-expressing bone marrow cells. These findings suggest that IRF-2 plays an important role in megakaryopoiesis in inflammatory states.
|
Authors | Atsuko Masumi, Isao Hamaguchi, Madoka Kuramitsu, Takuo Mizukami, Kazuya Takizawa, Haruka Momose, Seishiro Naito, Kazunari Yamaguchi |
Journal | FEBS letters
(FEBS Lett)
Vol. 583
Issue 21
Pg. 3493-500
(Nov 03 2009)
ISSN: 1873-3468 [Electronic] England |
PMID | 19818776
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interferon Regulatory Factor-2
- Platelet Membrane Glycoprotein IIb
- Interferon-gamma
|
Topics |
- Animals
- Bone Marrow
- Cell Differentiation
(drug effects)
- Cell Line
- Hematopoietic Stem Cells
(cytology, metabolism)
- Humans
- Inflammation
(metabolism)
- Interferon Regulatory Factor-2
(genetics, metabolism)
- Interferon-gamma
(pharmacology)
- Megakaryocytes
(cytology, metabolism)
- Mice
- Mice, Inbred C57BL
- Platelet Membrane Glycoprotein IIb
(genetics, metabolism)
- Promoter Regions, Genetic
(genetics)
- Rats
- Transcriptional Activation
(drug effects)
|